Business Wire15h
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) ...
Healio1d
RapidAI may be more accurate than VizAI in detecting large vessel occlusion
RapidAI automated imaging appeared to be more accurate than VizAI in detecting cases of large vessel occlusion, as well as in ...